4.7 Review

Hematology Emergencies in Critically Ill Adults Benign Hematology

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study

Fadi Fakhouri et al.

Summary: The study on eculizumab discontinuation in patients with atypical hemolytic uremic syndrome (aHUS) showed that a strategy based on complement genetics is reasonable and safe, improving patient management and quality of life while reducing treatment costs.
Article Urology & Nephrology

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults

Thomas Barbour et al.

Summary: Ravulizumab demonstrates long-term efficacy and safety in adults with aHUS, providing additional clinical benefits beyond 6 months of treatment, with most adverse events occurring early during the initial evaluation period and decreasing over time.

KIDNEY INTERNATIONAL REPORTS (2021)

Article Medicine, General & Internal

Systemic autoimmune disorders associated with thrombotic microangiopathy: A cross-sectional analysis from the French National TMA registry: Systemic autoimmune disease-associated TMA

Nihal Martis et al.

Summary: The study compared clinical features and treatment outcomes between patients with systemic autoimmune disease-associated thrombotic microangiopathies and those with atypical hemolytic uremic syndrome. Results showed that patients with SAID-TMA generally had pre-existing chronic kidney failure and were less likely to recover if renal replacement therapy was needed at onset. Treatment with immunosuppressive drugs was found to be more effective than therapeutic plasma exchange for SAID-TMA management.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Article Multidisciplinary Sciences

Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era

Andry van de Louw et al.

Summary: Immediate TPE and early rituximab therapy are associated with improved survival in TTP patients. The use of improved treatments has led to a decrease in mortality over time, and other outcome variables such as hospital resource utilization or long-term outcomes should be considered.

PLOS ONE (2021)

Review Urology & Nephrology

Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review

Philip A. McFarlane et al.

Summary: TMA encompasses various diseases like thrombotic thrombocytopenic purpura, postinfectious HUS, TMA associated with a coexisting condition, and aHUS. The process of identifying TMA can be broken down into two steps, requiring rapid and accurate determination of the etiology and prompt treatment.

CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE (2021)

Article Hematology

ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura

X. Long Zheng et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

ISTH guidelines for treatment of thrombotic thrombocytopenic purpura

X. Long Zheng et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Critical Care Medicine

Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems

Shinjiro Saito et al.

JOURNAL OF CRITICAL CARE (2019)

Review Hematology

An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura

Berangere S. Joly et al.

EXPERT REVIEW OF HEMATOLOGY (2019)

Article Pharmacology & Pharmacy

Successful management of the potentially fatal hyperhaemolysis syndrome of sickle cell anaemia with a regimen including bortezomib and Hemopure

Stacy S. Epstein et al.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)

Article Critical Care Medicine

Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura

Elie Azoulay et al.

INTENSIVE CARE MEDICINE (2019)

Article Medicine, General & Internal

Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

M. Scully et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Education, Scientific Disciplines

Clinical and laboratory diagnosis of TTP: an integrated approach

Thita Chiasakul et al.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)

Review Hematology

How I treat disseminated intravascular coagulation

Marcel Levi et al.

Article Hematology

Guidelines for the use of platelet transfusions

Lise J. Estcourt et al.

BRITISH JOURNAL OF HAEMATOLOGY (2017)

Review Medicine, General & Internal

Thrombotic microangiopathies: a general approach to diagnosis and management

Donald M. Arnold et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2017)

Review Hematology

Diagnosis and management of catastrophic antiphospholipid syndrome

Or Carmi et al.

EXPERT REVIEW OF HEMATOLOGY (2017)

Review Hematology

HUS and atypical HUS

T. Sakari Jokiranta

Review Hematology

Thrombotic thrombocytopenic purpura

Berangere S. Joly et al.

Review Rheumatology

Treatment of catastrophic antiphospholipid syndrome

Nayef M. Kazzaz et al.

CURRENT OPINION IN RHEUMATOLOGY (2016)

Article Education, Scientific Disciplines

Sickle cell disease: when and how to transfuse

Jo Howard

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)

Article Hematology

Guideline on the management of acute chest syndrome in sickle cell disease

Jo Howard et al.

BRITISH JOURNAL OF HAEMATOLOGY (2015)

Review Medicine, General & Internal

Rituximab in autoimmune thrombotic thrombocytopenic purpura: A success story

Antoine Froissart et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2015)

Article Critical Care Medicine

Antiphospholipid antibodies in critically ill patients with cancer: A prospective cohort study

Juliana Vassalo et al.

JOURNAL OF CRITICAL CARE (2014)

Article Medicine, General & Internal

Adult haemophagocytic syndrome

Manuel Ramos-Casals et al.

LANCET (2014)

Review Medicine, General & Internal

Syndromes of Thrombotic Microangiopathy

James N. George et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome

C. M. Legendre et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Hematology

Systemic infections mimicking thrombotic thrombocytopenic purpura

Kristina K. Booth et al.

AMERICAN JOURNAL OF HEMATOLOGY (2011)

Article Hematology

Plasmatherapy in Atypical Hemolytic Uremic Syndrome

Chantal Loirat et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)

Article Hematology

Guidelines for the diagnosis and management of disseminated intravascular coagulation

M. Levi et al.

BRITISH JOURNAL OF HAEMATOLOGY (2009)

Review Medicine, General & Internal

MEDICAL PROGRESS Atypical Hemolytic-Uremic Syndrome

Marina Noris et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Editorial Material Hematology

Hyperhemolysis syndrome in sickle cell disease

Nay Win

EXPERT REVIEW OF HEMATOLOGY (2009)

Article Education, Scientific Disciplines

Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC)

C. S. Kitchens

Hematology-American Society of Hematology Education Program (2009)

Review Medicine, General & Internal

Pulmonary Complications of Sickle Cell Disease.

Mark T. Gladwin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Oncology

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

Jan-Inge Henter et al.

PEDIATRIC BLOOD & CANCER (2007)

Review Medicine, General & Internal

Purpura fulminans in sepsis

Alex P. Betrosian et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2006)

Article Medicine, General & Internal

Causes and outcomes of the acute chest syndrome in sickle cell disease.

EP Vichinsky et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)